Leukemia Clinical Trials

Showing 541-560 of 5,235 trials

A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

NCT01425632

The objectives of this study are: to confirm the superiority of TAU-284 over placebo after two weeks of administration to pediatric patients with perennial allergic rhinitis, and to investigate the dose response, safety, and plasma concentrations of TAU-284.

Perennial Allergic Rhinitis

Tanabe Pharma Corporation490 participantsStarted Aug 2011

Chūbu, Japan • Hokuriku, Japan • Kanto, Japan +2 more locations

ACTIVE_NOT_RECRUITINGPHASE2

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

NCT01746849

The purpose of this study is to help determine if palifermin and leuprolide acetate can help the immune system recover faster following a stem cell transplant. Blood stem cells are very young blood cells that grow in the body to become red or white blood cells or platelets. The transplant uses stem cells in the blood from another person. The donor can be a family member or a volunteer donor. This is called an allogeneic stem cell transplant. The investigators want to see if palifermin and leuprolide acetate can help the immune system recover faster after an allogenic transplant because experiments have shown they may be able to do this.

LeukemiaMultiple MyelomaMyelodysplastic Syndrome+1 more

Memorial Sloan Kettering Cancer Center82 participantsStarted Dec 2012

New York, New York, United States

ACTIVE_NOT_RECRUITINGPHASE1

ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL

NCT02787369

This research study is studying a drug called ACY-1215 in combination with ibrutinib or idelalisib as a possible treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL).

Recurrent Chronic Lymphoid Leukemia

Dana-Farber Cancer Institute3 participantsStarted May 2016

Boston, Massachusetts, United States

A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL

Related Searches

Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.

Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)

Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy

TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL)

DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

Arterial Stiffness Intercostal Muscle Oxygenation and Aerobic-Anaerobic Capacity in Elite American Football Players

A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AML

C-TIL051 in Non-Small Cell Lung Cancer

Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)

Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China

CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)